Cord Blood Banking in the Arab World: Current Status and Future Developments

Area of Science:

• Regenerative Medicine
• Biobanking
• Public Health Policy

Background:

• Umbilical cord blood (CB) is a vital source for treating immune, blood, and genetic disorders.
• CB banks are essential for processing and storing CB units for therapeutic use.
• The expansion of CB banking presents unique ethical and regulatory challenges, particularly in emerging markets.

Purpose of the Study:

• To review and analyze CB banking policies and initiatives in five Arab countries: Jordan, Saudi Arabia, Egypt, Qatar, and the UAE.
• To identify regional trends, ethical considerations, religious perspectives, and demographic risk factors influencing CB banking.
• To assess the current state and future potential of CB banking in the Arab world.

Main Methods:

• Comparative case study analysis of CB banking policies across selected Arab nations.
• Review of regional initiatives, ethical frameworks, and regulatory landscapes.
• Assessment of demographic factors and religious viewpoints impacting CB banking.

Main Results:

• Significant regional variations in CB banking policies and initiatives were observed.
• Religious perspectives and demographic risk factors play a role in shaping regional policies.
• There is a notable deficit in public awareness and knowledge regarding CB banking in the region.

Conclusions:

• Strong incentives exist to increase the collection and availability of CB units for Arab populations.
• Addressing the knowledge gap on public opinion is crucial for informed decision-making in CB banking.
• Further research and policy development are needed to optimize CB banking in the Arab world.